Zileuton IV, an intravenous form of the drug Zyflo, has shown promising results in a new clinical trial for treating acute asthma attacks. Patients in the study who were dosed with the IV drug showed a greater improvement in breathing ability at 10-minute, 30-minute, and 60-minute intervals than those who took a placebo. Zileuton IV is being developed for use in emergency rooms and urgent care centers for patients who suffer acute asthma attacks.
Read moreBlack box warnings are a type of labeling that the Federal Drug Administration (FDA, for short) requires pharmaceutical companies to use... Read more »
Acorda Therapeutics and the FDA have informed healthcare professionals of changes to the CONTRAINDICATIONS and WARNINGS Sections of the... Read more »
Acorda Therapeutics and the FDA have informed healthcare professionals of changes to the CONTRAINDICATIONS and WARNINGS Sections of the... Read more »
A cure for asthma is not likely. That's the bad news. The good news is that asthma deaths have decreased and advances in... Read more »
Source: First DataBank
Generic Name: ZILEUTON EXTENDED-RELEASE - ORALPronounced: (zye-LOO-ton)Uses This medication is used to prevent asthma symptoms and to decrease... Read more »
Source: First DataBank
Generic Name: ZILEUTON - ORAL Pronounced: (zye-LOO-ton) Side Effects Nausea, drowsiness, constipation, dizziness, trouble sleeping, gas, joint... Read more »
Source: First DataBank
Generic Name: ERGOTAMINE - SUBLINGUAL Pronounced: (er-GOT-uh-meen) Interactions (See also Warning section and How to Use section.) Your doctor or... Read more »
Source: First DataBank
Generic Name: TIZANIDINE - ORAL Pronounced: (tize-AN-ih-deen) Interactions Your healthcare professionals (e.g., doctor or pharmacist) may already... Read more »
What is the concern about Singulair (montelukast)?Singulair is a major drug in asthma treatment – it is important to review recent developments and... Read more »